Raif Geha - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 
Area:
Molecular Biology

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Janssen E, Peters Z, Alosaimi MF, Smith E, Milin E, Stafstrom K, Wallace JG, Platt CD, Chou J, El Ansari YS, Al Farsi T, Ameziane N, Al-Ali R, Calvo M, Rocha ME, ... ... Geha RS, et al. Immune dysregulation caused by homozygous mutations in CBLB. The Journal of Clinical Investigation. PMID 36006710 DOI: 10.1172/JCI154487  0.351
2021 Rais A, Mekki N, Fedhila F, Alosaimi MF, Ben Khaled M, Zameli A, Agrebi N, Sellami MK, Geha R, Ben-Mustapha I, Barbouche MR. Case Report: Mutation in a Patient Presenting With ALPS. Frontiers in Immunology. 12: 692107. PMID 34531853 DOI: 10.3389/fimmu.2021.692107  0.326
2020 Lorenzini T, Fliegauf M, Klammer N, Frede N, Proietti M, Bulashevska A, Camacho-Ordonez N, Varjosalo M, Kinnunen M, de Vries E, van der Meer JWM, Ameratunga R, Roifman CM, Schejter YD, Kobbe R, ... ... Geha R, et al. Characterization of the clinical and immunological phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. The Journal of Allergy and Clinical Immunology. PMID 32278790 DOI: 10.1016/J.Jaci.2019.11.051  0.338
2020 Kumari S, Mak M, Poh YC, Tohme M, Watson N, Melo M, Janssen E, Dustin M, Geha R, Irvine DJ. Cytoskeletal tension actively sustains the migratory T-cell synaptic contact. The Embo Journal. e102783. PMID 31894880 DOI: 10.15252/Embj.2019102783  0.307
2018 Meshaal SS, El Hawary RE, Abd Elaziz DS, Eldash A, Alkady R, Lotfy S, Mauracher AA, Opitz L, Pachlopnik Schmid J, van der Burg M, Chou J, Galal NM, Boutros JA, Geha R, Elmarsafy AM. Phenotypic Heterogeneity in RAG-deficient Patients from a Highly Consanguineous Population. Clinical and Experimental Immunology. PMID 30307608 DOI: 10.1111/Cei.13222  0.369
2018 Borzutzky A, Rauter I, Fried A, Rachid R, McDonald DR, Hammarstrom L, Grimbacher B, Abraham RS, Geha RS. Defective TLR9-driven STAT3 activation in B cells of patients with CVID. Clinical Immunology (Orlando, Fla.). PMID 30145329 DOI: 10.1016/j.clim.2018.08.008  0.314
2018 Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom D, Lucena JM, Seidl M, ... ... Geha R, et al. Phenotype, penetrance, and treatment of 133 CTLA-4-insufficient individuals. The Journal of Allergy and Clinical Immunology. PMID 29729943 DOI: 10.1016/J.Jaci.2018.02.055  0.388
2017 Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Al-Herz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, ... ... Geha R, et al. Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A(+++) Cells, and Yet Display Increased Degranulation and Higher Perforin Content. Frontiers in Immunology. 8: 1244. PMID 29042861 DOI: 10.3389/Fimmu.2017.01244  0.307
2017 Massaad MJ, Cangemi B, Al-Herz W, LeFranc G, Freeman A, Baxi S, Keles S, Metin A, Dasouki M, Sobh A, Kanariou M, Al-Sukaiti N, Ozen A, Ochs H, Chatila TA, ... ... Geha R, et al. DOCK8 and STAT3 dependent inhibition of IgE isotype switching by TLR9 ligation in human B cells. Clinical Immunology (Orlando, Fla.). PMID 28882618 DOI: 10.1016/J.Clim.2017.08.020  0.346
2017 Marquardsen FA, Baldin F, Wunderer F, Al-Herz W, Mikhael R, Lefranc G, Baz Z, Rezaee F, Hanna R, Kfir-Erenfeld S, Stepensky P, Meyer B, Jauch A, Bigler MB, Burgener AV, ... ... Geha R, et al. Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency. Journal of Clinical Immunology. PMID 28825155 DOI: 10.1007/S10875-017-0431-5  0.307
2017 Platt CD, Fried AJ, Hoyos-Bachiloglu R, Naheed Usmani G, Schmidt B, Whangbo J, Chiarle R, Chou J, Geha RS. Combined immunodeficiency with EBV positive B cell lymphoma and epidermodysplasia verruciformis due to a novel homozygous mutation in RASGRP1. Clinical Immunology (Orlando, Fla.). PMID 28822832 DOI: 10.1016/J.Clim.2017.08.007  0.317
2017 Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Al-Herz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, ... ... Geha R, et al. Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A(+++) Cells, and Yet Display Increased Degranulation and Higher Perforin Content. Frontiers in Immunology. 8: 798. PMID 28769923 DOI: 10.3389/Fimmu.2017.00798  0.407
2017 Petersheim D, Massaad MJ, Lee S, Scarselli A, Cancrini C, Moriya K, Sasahara Y, Lankester AC, Dorsey M, Di Giovanni D, Bezrodnik L, Ohnishi H, Nishikomori R, Tanita K, Kanegane H, ... ... Geha RS, et al. Severe disease and greater impairment of NF-κB activation in IκBa point mutants versus truncation mutants in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency. The Journal of Allergy and Clinical Immunology. PMID 28629746 DOI: 10.1016/J.Jaci.2017.05.030  0.304
2016 Massaad MJ, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, Glauzy S, Olson BG, Morbach H, Ohsumi TK, Schmitz K, Kyriacos M, Kane J, Torisu K, Nakabeppu Y, ... ... Geha RS, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. The Journal of Clinical Investigation. PMID 27760045 DOI: 10.1172/Jci85647  0.337
2016 Jabara HH, Lee JJ, Janssen E, Ullas S, Liadaki K, Garibyan L, Benson H, Sannikova T, Bram R, Hammarstrom L, Cruz AC, Siegel R, Manis J, Malley R, Geha RS. Heterozygosity for TACI A144E causes haploinsufficiency and pneumococcal susceptibility in mice. The Journal of Allergy and Clinical Immunology. PMID 27609654 DOI: 10.1016/J.Jaci.2016.07.028  0.635
2015 Walter JE, Rosen LB, Csomos K, Rosenberg JM, Mathew D, Keszei M, Ujhazi B, Chen K, Lee YN, Tirosh I, Dobbs K, Al-Herz W, Cowan MJ, Puck J, Bleesing JJ, ... ... Geha R, et al. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. The Journal of Clinical Investigation. PMID 26457731 DOI: 10.1172/Jci80477  0.392
2015 Romberg N, Virdee M, Chamberlain N, Oe T, Schickel JN, Perkins T, Cantaert T, Rachid R, Rosengren S, Palazzo R, Geha R, Cunningham-Rundles C, Meffre E. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development. The Journal of Allergy and Clinical Immunology. 136: 1315-25. PMID 26100089 DOI: 10.1016/J.Jaci.2015.05.012  0.455
2015 Mooster JL, Le Bras S, Massaad MJ, Jabara H, Yoon J, Galand C, Heesters BA, Burton OT, Mattoo H, Manis J, Geha RS. Defective lymphoid organogenesis underlies the immune deficiency caused by a heterozygous S32I mutation in IκBα. The Journal of Experimental Medicine. 212: 185-202. PMID 25601653 DOI: 10.1084/Jem.20140979  0.765
2015 Charbonnier LM, Janssen E, Chou J, Ohsumi TK, Keles S, Hsu JT, Massaad MJ, Garcia-Lloret M, Hanna-Wakim R, Dbaibo G, Alangari AA, Alsultan A, Al-Zahrani D, Geha RS, Chatila TA. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. The Journal of Allergy and Clinical Immunology. 135: 217-27. PMID 25468195 DOI: 10.1016/J.Jaci.2014.10.019  0.344
2014 Turvey SE, Durandy A, Fischer A, Fung SY, Geha RS, Gewies A, Giese T, Greil J, Keller B, McKinnon ML, Neven B, Rozmus J, Ruland J, Snow AL, Stepensky P, et al. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency. The Journal of Allergy and Clinical Immunology. 134: 276-84. PMID 25087226 DOI: 10.1016/j.jaci.2014.06.015  0.306
2014 Al-Zahrani D, Raddadi A, Massaad M, Keles S, Jabara HH, Chatila TA, Geha R. Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency. Clinical Immunology (Orlando, Fla.). 153: 104-8. PMID 24743019 DOI: 10.1016/J.Clim.2014.04.005  0.333
2014 Lee YN, Frugoni F, Dobbs K, Walter JE, Giliani S, Gennery AR, Al-Herz W, Haddad E, LeDeist F, Bleesing JH, Henderson LA, Pai SY, Nelson RP, El-Ghoneimy DH, El-Feky RA, ... ... Geha RS, et al. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. The Journal of Allergy and Clinical Immunology. 133: 1099-108. PMID 24290284 DOI: 10.1016/J.Jaci.2013.10.007  0.333
2014 McDonald DR, Geha RS. Human Immunodeficiencies Resulting From Defective NF-κB Activation Stiehm's Immune Deficiencies. 665-686. DOI: 10.1016/B978-0-12-405546-9.00033-9  0.312
2013 Romberg N, Chamberlain N, Saadoun D, Gentile M, Kinnunen T, Ng YS, Virdee M, Menard L, Cantaert T, Morbach H, Rachid R, Martinez-Pomar N, Matamoros N, Geha R, Grimbacher B, et al. CVID-associated TACI mutations affect autoreactive B cell selection and activation. The Journal of Clinical Investigation. 123: 4283-93. PMID 24051380 DOI: 10.1172/Jci69854  0.471
2012 Oyoshi MK, He R, Li Y, Mondal S, Yoon J, Afshar R, Chen M, Lee DM, Luo HR, Luster AD, Cho JS, Miller LS, Larson A, Murphy GF, Geha RS. Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation. Immunity. 37: 747-58. PMID 23063331 DOI: 10.1016/j.immuni.2012.06.018  0.341
2012 Chou J, Hanna-Wakim R, Tirosh I, Kane J, Fraulino D, Lee YN, Ghanem S, Mahfouz I, Mégarbané A, Lefranc G, Inati A, Dbaibo G, Giliani S, Notarangelo LD, Geha RS, et al. A novel homozygous mutation in recombination activating gene 2 in 2 relatives with different clinical phenotypes: Omenn syndrome and hyper-IgM syndrome. The Journal of Allergy and Clinical Immunology. 130: 1414-6. PMID 22841008 DOI: 10.1016/J.Jaci.2012.06.012  0.365
2011 Ozcan E, Rauter I, Garibyan L, Dillon SR, Geha RS. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation. The Journal of Allergy and Clinical Immunology. 128: 601-9.e1-4. PMID 21741080 DOI: 10.1016/J.Jaci.2011.04.052  0.634
2010 Lee JJ, Jabara HH, Garibyan L, Rauter I, Sannikova T, Dillon SR, Bram R, Geha RS. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. The Journal of Allergy and Clinical Immunology. 126: 1234-41.e2. PMID 20889194 DOI: 10.1016/J.Jaci.2010.08.017  0.631
2010 Mooster JL, Cancrini C, Simonetti A, Rossi P, Di Matteo G, Romiti ML, Di Cesare S, Notarangelo L, Geha RS, McDonald DR. Immune deficiency caused by impaired expression of nuclear factor-kappaB essential modifier (NEMO) because of a mutation in the 5' untranslated region of the NEMO gene. The Journal of Allergy and Clinical Immunology. 126: 127-32.e7. PMID 20542322 DOI: 10.1016/j.jaci.2010.04.026  0.751
2010 Lee J, Jabara H, Garibyan L, Rauter I, Sannikova T, Dillon S, Bram R, Geha R. The Murine Equivalent of the Heterozygous C104R TACI Mutation Impairs B Cell Function via Haploinsufficiency Journal of Allergy and Clinical Immunology. 125: AB56. DOI: 10.1016/J.Jaci.2009.12.944  0.648
2010 Romberg N, Saadoun D, Rachid R, Geha R, Grimbacher B, Cunningham-Rundles C, Meffre E. Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand Interactor (TACI) Expression is Essential for Human B-cell Tolerance Journal of Allergy and Clinical Immunology. 125: AB125. DOI: 10.1016/J.Jaci.2009.12.495  0.343
2010 McDonald D, Goldman F, Gomez O, Issekutz A, Kumararatne D, Geha R. Impaired T Cell Receptor Activation in IRAK-4-Deficient Patients Clinical Immunology. 135: S102. DOI: 10.1016/J.Clim.2010.03.306  0.357
2009 Lee JJ, Rauter I, Garibyan L, Ozcan E, Sannikova T, Dillon SR, Cruz AC, Siegel RM, Bram R, Jabara H, Geha RS. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Blood. 114: 2254-62. PMID 19605846 DOI: 10.1182/Blood-2008-11-189720  0.649
2009 Ozcan E, Garibyan L, Lee JJ, Bram RJ, Lam KP, Geha RS. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells. The Journal of Allergy and Clinical Immunology. 123: 1277-86.e5. PMID 19427685 DOI: 10.1016/J.Jaci.2009.03.019  0.632
2009 Jin H, Kumar L, Mathias C, Zurakowski D, Oettgen H, Gorelik L, Geha R. Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization. The Journal of Allergy and Clinical Immunology. 123: 875-82.e1. PMID 19348925 DOI: 10.1016/J.Jaci.2009.02.007  0.367
2009 Ramesh N, Geha R. Recent advances in the biology of WASP and WIP. Immunologic Research. 44: 99-111. PMID 19018480 DOI: 10.1007/S12026-008-8086-1  0.321
2009 Ozcan E, Garibyan L, Lee J, Geha R. TACI Drives Plasma Cell Differentiation in LPS Activated B Cells Journal of Allergy and Clinical Immunology. 123: S94-S94. DOI: 10.1016/J.Jaci.2008.12.335  0.61
2008 Lee JJ, Ozcan E, Rauter I, Geha RS. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Current Opinion in Allergy and Clinical Immunology. 8: 520-6. PMID 18978466 DOI: 10.1097/ACI.0b013e3283141200  0.33
2008 He R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, Geha RS. TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proceedings of the National Academy of Sciences of the United States of America. 105: 11875-80. PMID 18711124 DOI: 10.1073/Pnas.0801532105  0.629
2008 Castigli E, Geha RS. TACI, isotype switching, CVID and IgAD. Immunologic Research. 38: 102-11. PMID 17917015 DOI: 10.1007/s12026-007-8000-2  0.318
2008 PAI S, LEVY O, JABARA H, GLICKMAN J, SACHS J, NURKO S, ORANGE J, GEHA R. Successful Correction of Immune Defects in a Patient with NEMO Mutation by Allogeneic Transplantation Uncovers Intrinsic Epithelial Basis for Colitis Journal of Allergy and Clinical Immunology. 121: S169-S169. DOI: 10.1016/J.Jaci.2007.12.621  0.362
2008 LEE J, GARIBYAN L, BRAM R, GEHA R. Murine Model of the Human TACI Mutation A181E Journal of Allergy and Clinical Immunology. 121: S144-S144. DOI: 10.1016/J.Jaci.2007.12.1111  0.631
2007 McDonald DR, Mooster JL, Reddy M, Bawle E, Secord E, Geha RS. Heterozygous N-terminal deletion of IkappaBalpha results in functional nuclear factor kappaB haploinsufficiency, ectodermal dysplasia, and immune deficiency. The Journal of Allergy and Clinical Immunology. 120: 900-7. PMID 17931563 DOI: 10.1016/J.Jaci.2007.08.035  0.748
2007 Castigli E, Wilson SA, Elkhal A, Ozcan E, Garibyan L, Geha RS. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation. The Journal of Allergy and Clinical Immunology. 120: 885-91. PMID 17689597 DOI: 10.1016/J.Jaci.2007.06.012  0.644
2007 Garibyan L, Lobito AA, Siegel RM, Call ME, Wucherpfennig KW, Geha RS. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). The Journal of Clinical Investigation. 117: 1550-7. PMID 17492055 DOI: 10.1172/Jci31023  0.631
2007 Castigli E, Wilson S, Garibyan L, Rachid R, Bonilla F, Schneider L, Morra M, Curran J, Geha R. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nature Genetics. 39: 430-1. PMID 17392798 DOI: 10.1038/Ng0407-430  0.607
2006 Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. The Journal of Allergy and Clinical Immunology. 117: 740-6; quiz 747. PMID 16630927 DOI: 10.1016/j.jaci.2006.01.038  0.331
2006 McDonald DR, Janssen R, Geha R. Lessons learned from molecular defects in nuclear factor kappaB dependent signaling. Microbes and Infection / Institut Pasteur. 8: 1151-6. PMID 16517203 DOI: 10.1016/J.Micinf.2005.10.030  0.326
2005 Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nature Genetics. 37: 829-34. PMID 16007086 DOI: 10.1038/Ng1601  0.659
2003 Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. The X-Linked Hyper-IgM Syndrome: Clinical and Immunologic Features of 79 Patients Medicine. 82: 373-384. PMID 14663287 DOI: 10.1097/01.Md.0000100046.06009.B0  0.303
2003 Bryce PJ, Geha R, Oettgen HC. Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma. The Journal of Allergy and Clinical Immunology. 112: 149-58. PMID 12847492 DOI: 10.1067/Mai.2003.1616  0.315
2003 Chapel H, Geha R, Rosen F. Primary immunodeficiency diseases: an update. Clinical and Experimental Immunology. 132: 9-15. PMID 12653830 DOI: 10.1046/J.1365-2249.2003.02110.X  0.35
2002 Orange JS, Brodeur SR, Jain A, Bonilla FA, Schneider LC, Kretschmer R, Nurko S, Rasmussen WL, Köhler JR, Gellis SE, Ferguson BM, Strominger JL, Zonana J, Ramesh N, Ballas ZK, ... Geha RS, et al. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. The Journal of Clinical Investigation. 109: 1501-9. PMID 12045264 DOI: 10.1172/Jci14858  0.359
1998 Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, Aversa G, Terhorst C. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395: 462-9. PMID 9774102 DOI: 10.1038/26683  0.4
1997 Khan WN, Nilsson A, Mizoguchi E, Castigli E, Forsell J, Bhan AK, Geha R, Sideras P, Alt FW. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40. International Immunology. 9: 395-405. PMID 9088978 DOI: 10.1093/Intimm/9.3.395  0.403
1996 Jawahar S, Moody C, Chan M, Finberg R, Geha R, Chatila T. Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II). Clinical and Experimental Immunology. 103: 408-13. PMID 8608639 DOI: 10.1111/J.1365-2249.1996.Tb08295.X  0.349
1995 Ramesh N, Fuleihan R, Swinton P, Rosen FS, Geha R. A point mutation in exon 2 of the CD40 ligand gene causes the simultaneous expression of two defective mRNA species in X-linked hyperimmunoglobulinemia M Human Molecular Genetics. 4: 759-761. PMID 7543320 DOI: 10.1093/Hmg/4.4.759  0.322
1993 Ramesh N, Ramesh V, Gusella JF, Geha R. Chromosomal localization of the gene for human B-cell antigen CD40. Somatic Cell and Molecular Genetics. 19: 295-8. PMID 7687385 DOI: 10.1007/Bf01233077  0.327
1989 Schwartz D, Wong RCK, Chatila T, Arnaout A, Miller R, Geha R. Proliferation of highly purified T cells in response to signaling via surface receptors requires cell-cell contact. Journal of Clinical Immunology. 9: 151-158. PMID 2654172 DOI: 10.1007/Bf00916943  0.339
1989 Mourad W, Scholl P, Diaz A, Geha R, Chatila T. The staphylococcal toxic shock syndrome toxin 1 triggers b cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction Journal of Experimental Medicine. 170: 2011-2022. PMID 2584933 DOI: 10.1084/Jem.170.6.2011  0.37
1989 Vercelli D, Helm B, Marsh P, Padlan E, Geha RS, Gould H. The B-cell binding site on human immunoglobulin E. Nature. 338: 649-51. PMID 2468089 DOI: 10.1038/338649A0  0.316
1982 Reinherz EL, Geha R, Rappeport JM, Wilson M, Penta AC, Hussey RE, Fitzgerald KA, Daley JF, Levine H, Rosen FS, Schlossman SF. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proceedings of the National Academy of Sciences of the United States of America. 79: 6047-6051. PMID 6764536 DOI: 10.1073/Pnas.79.19.6047  0.333
1981 Reinherz EL, Geha R, Wohl ME, Morimoto C, Rosen FS, Schlossman SF. Immunodeficiency associated with loss of T4+ inducer T-cell function. The New England Journal of Medicine. 304: 811-6. PMID 6451805 DOI: 10.1056/Nejm198104023041403  0.355
1977 Geha RS, Mudawwar F, Schneeberger E. The specificity of T-cell helper factor in man. The Journal of Experimental Medicine. 145: 1436-48. PMID 301172 DOI: 10.1084/Jem.145.6.1436  0.373
Show low-probability matches.